Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Other Operating Expenses (2018 - 2022)

Dexcom (DXCM) has disclosed Other Operating Expenses for 8 consecutive years, with $1.7 million as the latest value for Q3 2023.

  • On a quarterly basis, Other Operating Expenses fell 5.56% to $1.7 million in Q3 2023 year-over-year; TTM through Jun 2024 was $1.7 million, a 143.59% increase, with the full-year FY2021 number at $87.1 million, up 3384.0% from a year prior.
  • Other Operating Expenses was $1.7 million for Q3 2023 at Dexcom, up from -$5.7 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $84.8 million in Q4 2021 to a low of -$5.7 million in Q4 2022.
  • A 4-year average of $10.1 million and a median of $1.8 million in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 3292.0% in 2021, then crashed 106.72% in 2022.
  • Dexcom's Other Operating Expenses stood at $2.5 million in 2020, then soared by 3292.0% to $84.8 million in 2021, then tumbled by 106.72% to -$5.7 million in 2022, then surged by 129.82% to $1.7 million in 2023.
  • Per Business Quant, the three most recent readings for DXCM's Other Operating Expenses are $1.7 million (Q3 2023), -$5.7 million (Q4 2022), and $1.8 million (Q3 2022).